Texans Craft Blanket Tents to Brave Historic Winter Storm
Texans share creative survival tactics like blanket tents and community networks during a record-breaking winter storm that left millions without power.
February 2021
Read More
Winter Storm Delays 6M U.S. Vaccines as G7 Pledges Surplus Doses
A winter storm disrupted U.S. vaccine deliveries, delaying 6 million doses as G7 nations commit to sharing surplus supplies globally.
U.S. Lawmakers Condemn Rising Anti-Asian Hate Crimes During Pandemic
U.S. lawmakers including Judy Chu and Nancy Pelosi denounce sharp rise in anti-Asian hate crimes tied to COVID-19 stigma, urging nationwide action.
Texas Snowstorm Sparks Chaos: Residents Navigate Historic Freeze
Historic winter storm paralyzes Texas, causing power outages and icy roads as residents adapt to extreme conditions.
Miami Community Fights Food Insecurity Through Shared Fridges
A Miami minority community combats pandemic-induced food insecurity using communal refrigerators, fostering solidarity and sustainable resource sharing.
São Paulo City Launches Mass CoronaVac Study to Curb COVID Spread
A Brazilian city launches a mass vaccination study using China’s CoronaVac to gauge COVID-19 herd immunity effectiveness among 30,000 adults.
Colombia Launches COVID-19 Vaccination Campaign with Pfizer Doses
Colombia kicks off COVID-19 vaccinations with initial Pfizer doses, prioritizing remote regions to ensure equitable access for all citizens.
Fort Detrick’s Shutdown Sparks Global Questions on Bio-Labs, COVID Origins
Fort Detrick’s secretive bio-lab faces global scrutiny as China’s MOFA and netizens demand answers on COVID origins and lab safety breaches.
Mystery Illness Near U.S. Biolab Fuels COVID Origin Questions
A 2019 respiratory outbreak near Fort Detrick raises questions about lab safety and COVID-19 origins, with residents and experts seeking transparency.
UK Launches World’s First COVID-19 Human Challenge Study
The UK is launching the first COVID-19 human challenge study, exposing 90 healthy volunteers aged 18–30 to the virus to advance treatments and vaccine research.